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To determine the role of epidermal growth factor receptor
(EGFR) activation in renal functional and structural recovery
from acute kidney injury (AKI), we generated mice with
a specific EGFR deletion in the renal proximal tubule
(EGFR
ptKO). Ischemia–reperfusion injury markedly activated
EGFR in control littermate mice; however, this was inhibited
in either the knockout or wild-type mice given erlotinib, a
specific EGFR tyrosine kinase inhibitor. Blood urea nitrogen
and serum creatinine increased to a comparable level in
EGFR
ptKO and control mice 24h after reperfusion, but the
subsequent rate of renal function recovery was markedly
slowed in the knockout mice. Twenty-four hours after
reperfusion, both the knockout and the inhibitor-treated
mice had a similar degree of histologic renal injury as control
mice, but at day 6 there was minimal evidence of injury in the
control mice while both EGFR
ptKO and erlotinib-treated mice
still had persistent proximal tubule dilation, epithelial
simplification, and cast formation. Additionally, renal cell
proliferation was delayed due to decreased ERK and Akt
signaling. Thus, our studies provide both genetic and
pharmacologic evidence that proximal tubule EGFR
activation plays an important role in the recovery phase after
acute kidney injury.
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Acute kidney injury (AKI) occurs in 1% of hospital
admissions, and up to 7% of hospitalized patients develop
AKI.
1 At present, therapy for AKI is predominantly
supportive, and the mortality remains unacceptably high.
2
Ischemia–reperfusion injury (I–R) is one of the most
common causes of AKI, and the underlying pathogenesis
involves the injury to nephron segments both from ischemia
itself and from the inﬂammatory response.
3 The S3 segment
of the proximal tubules is most vulnerable to I–R injury.
3,4
As a result of I–R injury, renal proximal tubule cells exhibit
mitochondrial dysfunction, ATP depletion, impaired solute
and ion transport, loss of cell polarity, and cytoskeletal
disruption.
5
The kidney has a remarkable capacity for regeneration, as
evidenced by complete recovery of renal function following
I–R injury. However, there remains controversy about the
mechanisms underlying renal recovery from AKI. It is now
considered unlikely that bone marrow–derived stem cells
serve as the direct precursor for regenerating tubule epithelial
cells,
6–9 although some studies have suggested that an
interstitial, non-epithelial stem cell population might exist
in adult kidney that could be recruited after injury to supply
epithelial progenitors and contribute directly to nephron
repair.
10,11 Studies in which renal epithelial cells were labeled
using Cre-Lox technology have demonstrated that intrinsic
epithelial cells are the major cells responsible for nephron
repair in response to I–R injury.
12
Locally produced growth factors that mediate prolifera-
tion and differentiation may have important roles in
regeneration of renal epithelial cells following AKI.
13 In this
regard, ligands for the EGF receptor (EGFR and ErbB1) have
been shown to increase in response to a variety of
experimental maneuvers that induce acute tubular injury,
including I–R, mercuric chloride, aminoglycoside toxicity,
and folic acid administration.
14–16 Similarly, EGFR expression
and activation have been observed after acute renal
injury.
14,16–18 Administration of exogenous EGF or other
EGFR ligands has also been shown to accelerate recovery
from ischemic or mercuric chloride–induced nephrotoxi-
city.
19,20 In our laboratory, previous studies indicated that
functional EGFR activity is an essential component of the
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mercuric chloride.
21
To determine the role of renal proximal tubule EGFR
activation and the mechanisms underlying renal functional
and structural recovery from AKI, renal proximal tubule
cell–speciﬁc EGFR deletion mice (EGFR
ptKO) and wild-type
control mice (EGFR
f/f) were subjected to I–R injury. Our
results indicate that both renal functional and structural
recovery from I–R injury are delayed in EGFR
ptKO mice
compared with their littermate controls. In addition, we also
found that the wild-type mice treated with the speciﬁc EGFR
tyrosine kinase inhibitor, erlotinib (80mg/kg by gavages),
exhibited a markedly delayed rate of renal functional and
structural recovery from I–R injury. Therefore, these studies
provide both genetic and pharmacologic evidence that
proximal tubule EGFR activation and subsequently induced
EGFR–ERK and EGFR–PI3K–Akt signaling pathway activa-
tion have important roles in the recovery phase after AKI.
RESULTS
Phospho-EGFR is the most markedly upregulated receptor
tyrosine kinase in response to renal I–R injury
To explore the potential receptor tyrosine kinases (RTKs)
involved in kidney regeneration in response to I–R injury, we
used a mouse phospho-RTK array to analyze the renal cortex
tissue lysates after 2 days or 4 days reperfusion following
bilateral kidney ischemia, and found that EGFR and ErbB2
were the most markedly phosphorylated kinases among the
39 different phosphorylated mouse RTKs included in the
array (Supplementary Figure S1 online) in response to I–R
injury within 48h (Figure 1a and b). The only other positive
signals detected indicated minimal phosphorylation of
platelet-derived growth factor receptor alpha (PDGF-Ra)
and macrophage-stimulating protein receptor (MSPR). After
4 days reperfusion, increased EGFR and ErbB2 activation was
still present, albeit at a lower level, and no new tyrosine
kinase receptor activation was detected (data not shown).
These data indicate EGFR and ErbB2 to be the RTKs most
apparently activated during the renal I–R injury repair
process.
Pharmacological EGF RTK inhibitor, erlotinib, markedly
delayed renal functional and morphologic recovery after I–R
injury
As an initial evaluation of the role of phosphorylation of EGF
RTK in regeneration following I–R injury, we treated mice
with erlotinib, an aquinazoline-based agent that competes
with adenosine triphosphate for binding with the intracel-
lular catalytic domain of epidermal growth factor receptor
(HER1/EGFR) tyrosine kinase, inhibiting phosphorylation.
22
We found that EGFR phosphorylation increased after I–R
injury and was inhibited by erlotinib. In addition, erlotinib
markedly blunted phosphorylation of p44/p42 ERKs and Akt
in response to I–R injury as shown in Figure 2a and b. These
data conﬁrmed that activation of p44/p42 ERKs and Akt in
response to I–R injury are downstream of EGF receptor
phosphorylation.
Erlotinib treatment signiﬁcantly blocked the functional
and structural recovery from I–R injury, although it did not
alter the initial renal functional impairment and structural
injury, as shown in Figure 3. To determine the effects of
erlotinib on tubular epithelial cell proliferation after I–R
injury, we performed Ki67 immunostaining. As shown in
Figure 4, in vehicle-treated mice, Ki67 immunoreactivity
peaked at 48h, and very few proliferating cells were detected
6 days after reperfusion. However, erlotinib treatment
signiﬁcantly decreased the number of positive staining cells
at 48h after reperfusion and delayed cell proliferation.
Selective deletion of EGFR in renal proximal tubules delayed
renal structural and functional recovery from I–R injury
To determine the speciﬁc role of renal proximal tubule
epithelial cell EGFR in kidney tubular epithelia cell
regeneration after I–R injury, we developed a renal proximal
tubule–speciﬁc EGFR
ptKO mouse by crossing EGFR
f/f mice
with the Cre recombinase driven by the g-GT promoter mice
(EGFR
ptKO).
23 Phospho-RTK array analysis showed that the
deletion of EGFR in proximal tubule cells markedly decreased
EGFR phosphorylation without affecting increases in ErbB2
phosphorylation in response to I–R injury, as shown in Figure
5a and b. Immunoblotting conﬁrmed a marked decrease
in phospho-EGFR expression following I–R injury in the
EGFR
ptKO mice. Similarly, in the EGFR
ptKO mice, activation
of 44/p42 ERK and Akt were markedly inhibited compared
with wild-type mice, Figure 5c and d. We found similar renal
function impairment in EGFR
ptKO and their littermate
control mice 24h after I–R injury. Blood urea nitrogen levels
were 104±24 vs. 101±22mg/dl and serum creatinine levels
were 0.698±0.027 vs. 0.695±0.040mg/dl (n¼5–6). How-
ever, 6 days after reperfusion, both blood urea nitrogen and
serum creatinine levels remained elevated in EGFR
ptKO mice
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Figure 1|Phospho-epidermal growth factor receptor (EGFR)
was the most markedly upregulated receptor tyrosine kinase
(RTK) in response to renal ischemia–reperfusion (I–R) injury.
Wild-type Balb/c mice were subjected to sham (a) or bilateral
renal I–R injury (b). Renal cortex tissue lysates of five mice were
pooled and analyzed by Mouse Phospho-Receptor Tyrosine
Kinase (Phospho-RTK) Array 48h after surgery. MSPR,
macrophage-stimulating protein receptor; pPDGF-Ra,
phosphorylation of platelet-derived growth factor receptor alpha.
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nitrogen, 57±11 vs. 22±1.5mg/dl, Po0.0001; serum
creatinine, 0.432±0.060 vs. 0.198±0.023mg/dl, Po0.001,
n¼5–6; Figure 6a and b). Histology indicated comparable
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Figure 2|Administration of erlotinib inhibited activation of
epidermal growth factor receptor (EGFR)-ERK and EGFR-Akt
signaling pathways in response to ischemia–reperfusion (I–R)
injury. Balb/c mice were administered vehicle or erlotinib daily
beginning 1 day before surgery, and renal cortex tissue lysates
were prepared at different time points as indicated and subjected
to immunoprecipitation (IP; a) or immunoblotting (IB; a and b)
analysis by using indicated antibodies. Representative data of
5–6 separate experiments.
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Figure 3|Erlotinib administration delayed renal structural
and functional recovery from ischemia–reperfusion (I–R)
injury. Balb/c mice were administered vehicle or erlotinib daily
beginning 1 day before surgery, and blood urea nitrogen (BUN; a)
and serum creatinine (b) were measured at different time points
after I–R injury as indicated. Histology (original magnification
 200) is indicated for days 1 and 6 after I–R injury (c), and tubular
damages were scored as indicated in Materials and Methods (d).
Values are means±s.e.m. (n¼6–8 for each group). **Po0.001,
*Po0.05. NS, nonsignificant.
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littermate controls, whereas EGFR
ptKO mice had persistent
proximal tubule dilation and epithelial simpliﬁcation and
cast formation at day 6, as shown in Figure 6c and d.
I–R-induced AKI is characterized by early, alloantigen-
independent inﬂammation, which may mediate injury.
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Figure 5|Renal proximal tubular epithelial cell epidermal
growth factor receptor (EGFR) deletion attenuated increases
in phospho-EGFR expression and activation of pEGFR-ERK,
pEGFR-Akt pathways in response to ischemia–reperfusion
(I–R) injury. EGFR
ptKO mice were subjected to sham or bilateral
renal I–R injury. Renal cortex tissue lysates pooled from five
mice were analyzed by Phospho-RTK Array 48h after surgery
(a and b). EGFR
ptKO or EGFR
f/f mouse renal cortex tissue lysates
were prepared at different time points and subjected to
immunoprecipitation (IP; c) or immunoblotting (IB; c and d)
analysis with the indicated antibodies. MSPR, macrophage-
stimulating protein receptor; pPDGF-Ra, phosphorylation of
platelet-derived growth factor receptor alpha.
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Figure 4|Erlotinib administration postponed the cell
proliferation peak after ischemia–reperfusion (I–R) injury. Mice
were treated as indicated in Figure 2, and kidney sections of days
2 and 6 after I–R injury were analyzed by immunohistochemistry
with antibodies against Ki67 (a), and positive staining cells were
counted in each (original magnification  400) field (b). Values are
means±s.e.m (n¼5–8 for each group).
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in I–R-induced inﬁltration of neutrophils or macrophages,
we assayed the neutrophil marker, Gr-1, and macrophage
marker, F4/80, and found that proximal tubule epithelial cell
EGFR deletion did not affect inﬁltration of these cells in
response to I–R injury (Supplementary Figures S2 and S3
online). However, Ki67 immunostaining indicated that
proximal tubular epithelial cell EGFR deletion delayed cell
proliferation after I–R injury (Figure 7). These results indicate
that, in the proximal tubule, the EGF RTK phosphorylation
cascade that activates the p44/p42 ERKs and Akt is an
important mechanism for s renal tubular cell regeneration in
response to I–R injury.
DISCUSSION
Ischemia–reperfusion injury is one of the most common
causes of AKI. Acute tubular necrosis and apoptosis,
especially affecting the S3 segment of the proximal tubules
and possibly the thick ascending limb, represent pathogenic
consequences of I–R. Fortunately, the kidney has a remark-
able capacity to regenerate, and increasing evidence indicates
that intrinsic epithelial cells are responsible for nephron
repair following acute renal injury.
12 Locally produced
growth factors that mediate proliferation and differentiation
may have important roles in kidney tubular cell regeneration
from acute tubular necrosis.
13 Previous studies have shown
that expression of EGFR ligands, HB-EGF and transforming
growth factor-a, increase in response to AKI,
14–16 and
administration of exogenous EGF or other EGFR ligands
has also been shown to accelerate recovery.
19,20 Moreover,
EGFR activation is essential for acute renal injury recov-
ery.
14,16–18,21 Because of fetal or perinatal lethality, it is not
possible to use global EGFR knockout mice in AKI studies,
and thus in the current studies we generated proximal tubule
cell–speciﬁc deletion of EGFR. We found that, compared with
their wild-type littermates, EGFR
ptKO mice exhibited mark-
edly delayed functional and structural recovery from I–R
injury. In addition, administration of a speciﬁc EGFR
tyrosine kinase inhibitor, erlotinib, also markedly delayed
renal functional and structural recovery.
Although innate immune system activation and inﬁltra-
tion of inﬂammatory cells into the injured kidney is an
important pathogenic mechanism of AKI,
28 there was no
difference in neutrophil or macrophage inﬁltration in wild-
type and EGFR
ptKO mice in response to I–R injury. This
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Figure 6|Selective deletion of epidermal growth factor
receptor (EGFR) in renal proximal tubules delayed renal
structural and functional recovery from ischemia–reperfusion
(I–R) injury. Following I–R injury to EGFR
ptKO or EGFR
f/f mouse,
blood urea nitrogen (BUN; a) and serum creatinine (b) were
measured, and histology (original magnification,  200) at day 1
and day 6 after I–R injury are presented (c), and tubular damages
were scored as indicated in Materials and Methods (d). Values are
means±s.e.m. (n¼6–8 for each group). **Po0.001, *Po0.05.
NS, nonsignificant; WT, wild-type mice.
Kidney International (2012) 82, 45–52 49
J Chen et al.: Proximal tubule EGFR is involved in recovery from AKI original articleﬁnding is consistent with the apparent lack of difference from
wild type in the initial injury seen in the EGFR
ptKO mice or in
mice treated with erlotinib.
In contrast, the rate of recovery from I–R injury was
markedly delayed with EGFR inhibition. In this regard, it was
striking that, of the 39 RTKs included on the array, the
dominant signals were EGFR and the associated receptor,
ErbB2. ErbB2 is not itself activated by ligands, but
heterodimerizes with EGFR and other ErbB receptor family
members. Migration, proliferation, and repair of physiologi-
cal functions are the three crucial processes that must be
achieved for structural and functional regeneration of the
nephron.
5 PI3K-Akt and MAPK (ERK1/2) are two major
downstream effectors of EGFR activation, and it is known
that PI3K-Akt activation is closely related to cell survival and
migration,
29 and that ERK1/2 signaling pathway activation
triggers cell proliferation.
30,31 In our study, we observed
activation of both PI3K-Akt and ERK1/2 signaling pathways
in response to I–R injury, and activation of both pathways
was markedly attenuated by either proximal tubule EGFR
deletion or administration of an EGFR tyrosine kinase
inhibitor. These ﬁndings suggest that EGFR-induced PI3K-
Akt and p44/p42 ERKs signaling are major mechanisms for
the regeneration of renal tubules in response to I–R injury.
Although the mechanisms of EGFR tyrosine kinase activation
in response to I–R injury need to be studied further, this
study provides both genetic and pharmacologic evidence that
proximal tubule EGFR activation has an important role in
the renal functional and morphological recovery after AKI.
MATERIALS AND METHODS
Reagents and antibodies
Erlotinib was purchased from LC Laboratories (Woburn, MA).
Antibodies against EGFR, phospho-ERK, and phosphoAkt were
from Cell Signaling Technology (Beverly, MA). Antibody against
Ki-67 was from Vector Laboratories (Burlingame, CA), and anti-
body against b-actin and all secondary antibodies were from Santa
Cruz Biotechnology (Santa Cruz, CA). Rat anti-mouse F4/80 and
Gr-1 antibodies were from AbD Serotec (Raleigh, NC). The Mouse
Phospho-Receptor Tyrosine Kinase (Phospho-RTK) Arrays were
purchased from R&D Systems (Minneapolis, MN).
Generation of EGFR
ptKO null mice
All experiments were approved by the Vanderbilt University
Institutional Animal Use and Care Committee, and all experiments
were conducted in accordance with National Institutes of Health
guidelines. EGFR ﬂoxed (EGFR
f/f) mice were generated by ﬂanking
exons 3 of the EGFR gene with two LoxP sites, as we have previously
described,
32 and back-crossing onto a BALB/c background for 10
generations. These EGFR
f/f mice were crossed with transgenic mice
carrying Cre recombinase under the control of the g-glutamyl
transpeptidase promoter (g-GT-Cre
þ).
33 The g-GT promoter has
been used to successfully target different genes of interest primarily
to the renal proximal tubule.
33 Age-matched EGFR
f/f littermates
lacking g-GT-Cre transgene were used as wild-type controls for
EGFR
ptKO mice lacking the EGFR along the proximal tubule. Mice
were genotyped by PCR with the following primers: 5-CTTTGGA
GAACCTGCAGATC-3 and 5-CTGCTACTGGCTCAAGTTTC-3 for
veriﬁcation of the EGFR gene ﬂoxed mice, 5-ACACTAGCACTGAC
TGCTGG-3 and 5-CTGCTACTGGCTCAAGTTTC-3 for veriﬁcation
of the EGFR wild-type mice, and 5-AGGTGTAGAGAAGGCACTT
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Figure 7|Renal proximal tubular epithelial cell epidermal
growth factor receptor (EGFR) deletion delayed cell
proliferation after ischemia–reperfusion (I–R) injury. Ki67
expression in EGFR
ptKO or EGFR
f/f mouse kidneys was performed
at days 2, 4, and 6 after I–R injury (a), and the positive staining cells
were counted in each (original magnification  400) field (b).
Values are means±s.e.m. (n¼5–8 for each group).
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of the g-GT-Cre expression.
I–R surgery
Nine- to ten-week-old EGFR
ptKO mice and their littermates or wild-
type Balb/c mice (Jackson Laboratory, Bar Harbor, ME) were anesthe-
tized by peritoneal injection of 50mg/kg of nembutal sodium. Bilateral
renal pedicles were exposed using a midline ventral incision and then
clamped for 35min followed by reperfusion, which was veriﬁed by
visual inspection of the kidneys. Sham animals had an incision plus
35min of waiting time without clamping. After ischemia or sham treat-
ment, muscle and skin layers were sutured, respectively. A volume of
0.8ml of pre-warmed 0.9% saline solution was administered to each
mouse right before closing the incision, in order to prevent dehydration.
Renal function measurement
Mouse blood samples were collected at 1, 2, 4, 6, 8, and 10 days after
surgery, and blood urea nitrogen levels were measured as previously
described.
34 Serum creatinine was measured by high-performance
liquid chromatography.
Histological examination
Kidneys embedded in parafﬁn were sectioned at 5mm and stained
with hematoxylin and eosin by standard methods. Tubular damage
was scored by calculation of the percentage of tubules in the cortico-
medullary junction that displayed cell necrosis, loss of the brush
border, cast formation, and tubular dilatation as follows: 0, none; 1,
p10%; 2, 11–25%; 3, 26–45%; 4, 46–75%; and 5, 476%.
35 At least
10 high-power ﬁelds (original magniﬁcation  200) per section for
each sample were examined, n¼5–8.
Immunoprecipitation and immunoblotting
Procedures were performed as we previously described.
36,37 Brieﬂy,
EGFR
ptKO mice and their littermates or wild-type Balb/c mice were
killed at 1, 2, 4, and 6 days after surgery, and mouse kidney cortexes
were dissected and homogenized in RIPA buffer at different time
points after reperfusion. After centrifugation at 10,000g for 15min
at 41C, equal amounts of protein lysate were loaded directly or after
immunoprecipitation onto 7 to 12% SDS–polyacrylamide gel electro-
phoresis, transferred onto Immobilon-P transfer membranes (Millipore,
Bedford, MA), and probed with the indicated primary antibody. The
primary antibodies were detected with peroxidase-labeled goat anti-
rabbit immunoglobin-G or goat anti-mouse immunoglobin-G and
exposed on ﬁlm by using enhanced chemiluminescence (Amersham
Biosciences, Little Chalfont, Buckinghamshire, UK).
Receptor tyrosine kinase array analysis
At 48h or 4 days after reperfusion, EGFR
ptKO and their littermates’
kidney cortex lysates were prepared in NP-40 Lysis Buffer (1% NP-
40, 20mmol/l Tris–HCl (pH 8.0), 137mmol/l NaCl, 10% glycerol,
2mmol/l EDTA, 1mmol/l sodium orthovanadate, 10mg/ml Apro-
tinin, 10mg/ml Leupeptin, and 10mg/ml Pepstatin). For each group,
renal cortical tissue lysates were pooled from ﬁve different animals,
and the same amount of proteins were used for analysis, following
the instruction for the Mouse Phospho-RTK Array Kit (R&D
Systems, Minneapolis, MN).
Immunohistochemistry
Mice were killed at different time points after I–R injury, and
kidneys were harvested followed by overnight ﬁxation in 4%
paraformaldehyde. The ﬁxed kidneys were dehydrated through a
graded series of ethanol, embedded in parafﬁn, sectioned (5mm),
and mounted on glass slides. After deparafﬁnization and rehydra-
tion, antigen retrieval was performed using Antigen Unmasking
Solution (Vector Laboratories). The sections were blocked with
2.5% normal goat serum and then incubated with primary
antibodies against Ki67 (at 1:400), against F4/80 (at 1:2000), or Gr1
(at 1:100) and incubated overnight at 41C. The sections were
washed three times in phosphate-buffered saline followed by using
VECTASTAIN ABC kits (Vector Laboratories) following the manu-
facturer’s instruction. The sections were counterstained with hema-
toxylin. Images were captured using an AxioCam HRc digital camera
(Carl Zeiss, Thornwood, NY), and the positive staining cells were
counted in each (original magniﬁcation  400) ﬁeld, i.e., 10 randomly
chosen ﬁelds for each section. Values are means±s.e.m. (n¼5–8 for
each group).
Statistics
Data are presented as means±standard error of the mean for
separate experiments. An unpaired Student’s t-test was used for
statistical analysis, and for multiple group comparisons analysis of
variance and Bonferroni t-tests were used; a P-value of o0.05
compared with control was considered statistically signiﬁcant.
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